Background & Aims In 2017, the World Health Organization (WHO) designated
clarithromycin-resistant Helicobacter pylori a high priority for antibiotic research and …

Background Helicobacter pylori is one of the most prevalent global pathogens and can lead
to gastrointestinal disease including peptic ulcers, gastric marginal zone lymphoma and …

Since the discovery of antibiotics by Sir Alexander Fleming they have been used throughout
medicine and play a vital role in combating microorganisms. However, with their vast use …

Introduction: Helicobacter pylori antibiotic resistance has increased worldwide and multidrug
resistance (MDR), which seriously hampers eradication success of the frequent chronic …

Helicobacter pylori-associated gastritis leads to the development of gastric cancer. Kyoto
global consensus report on H. pylori gastritis recommended H. pylori eradication therapy to …

Background H. pylori exhibits antibiotic resistance with regional differences. In this paper,
we explored antibiotic resistance of H. pylori to five antibiotics in an area with a high risk of …

Helicobacter pylori drug resistance presents a significant challenge to the successful
eradication of this pathogen. To find strategies to improve the eradication efficacy of H …

Background Helicobacter pylori is a spiral-shaped gram-negative bacteria associated with
peptic ulcer, gastritis and gastric cancer. The global burden and occurrence of H. pylori …

Helicobacter pylori (H. pylori) has acquired several resistance mechanisms in order to
escape the currently used eradication regimens such as mutations that impair the …

Antibiotic resistance is the most important factor leading to failed Helicobacter pylori
eradication therapy, and personalized treatment based on antibiotic susceptibility is …